Dilated cardiomyopathy in patients with hypoparathyroidism: A narrative review

Maryam Abdolmaleki1, Laya Ohadi1, Saba Maleki2

  • 1Shahid Beheshti University of Medical Sciences Tehran Iran.

Health Science Reports
|January 8, 2024
PubMed

Insights

Hypoparathyroidism can cause dilated cardiomyopathy (DCM), but timely calcium and vitamin D supplementation can reverse cardiac dysfunction. Patient adherence to treatment is key for managing this endocrine-related heart condition.

Area of Science:

  • Endocrinology
  • Cardiology

Background:

  • Hypoparathyroidism is a rare endocrine disorder marked by low calcium, high phosphorus, and insufficient parathyroid hormone.
  • This condition can lead to dilated cardiomyopathy (DCM), characterized by enlarged heart ventricles and impaired function.

Purpose of the Study:

  • To explore the link between hypoparathyroidism and DCM.
  • To investigate calcium's impact on cardiac function.
  • To assess the potential for DCM reversal with calcium supplementation.

Main Methods:

  • A comprehensive literature search was performed using PubMed and Google Scholar.
  • Included case reports of DCM in hypoparathyroidism patients.
  • Analyzed cases for cardiac manifestations, diagnostics, and management.

Main Results:

  • DCM in hypoparathyroidism presents with heart failure symptoms, reduced ejection fraction, and impaired left ventricular function.
  • Laboratory findings include low serum calcium and high phosphate levels.
  • Prompt treatment with calcium and vitamin D improved cardiac function.

Conclusions:

  • Hypoparathyroidism-induced DCM is reversible with timely calcium and vitamin D supplementation.
  • Patient compliance and regular monitoring are crucial for preventing cardiac complications.
  • Routine follow-up of DCM in endocrine disorder patients is recommended.
Abstract

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
2.1K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
544
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
168
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591